CD66a interactions between human melanoma and NK cells: a novel class I MHC-independent inhibitory mechanism of cytotoxicity.

NK cells are able to kill virus-infected and tumor cells via a panel of lysis receptors. Cells expressing class I MHC proteins are protected from lysis primarily due to the interactions of several families of NK receptors with both classical and nonclassical class I MHC proteins. In this study we sh...

Full description

Bibliographic Details
Main Authors: Markel, G, Lieberman, N, Katz, G, Arnon, T, Lotem, M, Drize, O, Blumberg, R, Bar-Haim, E, Mader, R, Eisenbach, L, Mandelboim, O
Format: Journal article
Language:English
Published: 2002
_version_ 1826288257590099968
author Markel, G
Lieberman, N
Katz, G
Arnon, T
Lotem, M
Drize, O
Blumberg, R
Bar-Haim, E
Mader, R
Eisenbach, L
Mandelboim, O
author_facet Markel, G
Lieberman, N
Katz, G
Arnon, T
Lotem, M
Drize, O
Blumberg, R
Bar-Haim, E
Mader, R
Eisenbach, L
Mandelboim, O
author_sort Markel, G
collection OXFORD
description NK cells are able to kill virus-infected and tumor cells via a panel of lysis receptors. Cells expressing class I MHC proteins are protected from lysis primarily due to the interactions of several families of NK receptors with both classical and nonclassical class I MHC proteins. In this study we show that a class I MHC-deficient melanoma cell line (1106mel) is stained with several Ig-fused lysis receptors, suggesting the expression of the appropriate lysis ligands. Surprisingly, however, this melanoma line was not killed by CD16-negative NK clones. The lack of killing is shown to be the result of homotypic CD66a interactions between the melanoma line and the NK cells. Furthermore, 721.221 cells expressing the CD66a protein were protected from lysis by YTS cells and by NK cells expressing the CD66a protein. Redirected lysis experiments demonstrated that the strength of the inhibitory effect is correlated with the levels of CD66a expression. Finally, the expression of CD66a protein was observed on NK cells derived from patients with malignant melanoma. These findings suggest the existence of a novel class I MHC-independent inhibitory mechanism of human NK cell cytotoxicity. This may be a mechanism that is used by some of the class I MHC-negative melanoma cells to evade attack by CD66a-positive NK cells.
first_indexed 2024-03-07T02:10:59Z
format Journal article
id oxford-uuid:a0a2c3ae-7088-4878-b0e7-a17d62e6bb21
institution University of Oxford
language English
last_indexed 2024-03-07T02:10:59Z
publishDate 2002
record_format dspace
spelling oxford-uuid:a0a2c3ae-7088-4878-b0e7-a17d62e6bb212022-03-27T02:06:55ZCD66a interactions between human melanoma and NK cells: a novel class I MHC-independent inhibitory mechanism of cytotoxicity.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:a0a2c3ae-7088-4878-b0e7-a17d62e6bb21EnglishSymplectic Elements at Oxford2002Markel, GLieberman, NKatz, GArnon, TLotem, MDrize, OBlumberg, RBar-Haim, EMader, REisenbach, LMandelboim, ONK cells are able to kill virus-infected and tumor cells via a panel of lysis receptors. Cells expressing class I MHC proteins are protected from lysis primarily due to the interactions of several families of NK receptors with both classical and nonclassical class I MHC proteins. In this study we show that a class I MHC-deficient melanoma cell line (1106mel) is stained with several Ig-fused lysis receptors, suggesting the expression of the appropriate lysis ligands. Surprisingly, however, this melanoma line was not killed by CD16-negative NK clones. The lack of killing is shown to be the result of homotypic CD66a interactions between the melanoma line and the NK cells. Furthermore, 721.221 cells expressing the CD66a protein were protected from lysis by YTS cells and by NK cells expressing the CD66a protein. Redirected lysis experiments demonstrated that the strength of the inhibitory effect is correlated with the levels of CD66a expression. Finally, the expression of CD66a protein was observed on NK cells derived from patients with malignant melanoma. These findings suggest the existence of a novel class I MHC-independent inhibitory mechanism of human NK cell cytotoxicity. This may be a mechanism that is used by some of the class I MHC-negative melanoma cells to evade attack by CD66a-positive NK cells.
spellingShingle Markel, G
Lieberman, N
Katz, G
Arnon, T
Lotem, M
Drize, O
Blumberg, R
Bar-Haim, E
Mader, R
Eisenbach, L
Mandelboim, O
CD66a interactions between human melanoma and NK cells: a novel class I MHC-independent inhibitory mechanism of cytotoxicity.
title CD66a interactions between human melanoma and NK cells: a novel class I MHC-independent inhibitory mechanism of cytotoxicity.
title_full CD66a interactions between human melanoma and NK cells: a novel class I MHC-independent inhibitory mechanism of cytotoxicity.
title_fullStr CD66a interactions between human melanoma and NK cells: a novel class I MHC-independent inhibitory mechanism of cytotoxicity.
title_full_unstemmed CD66a interactions between human melanoma and NK cells: a novel class I MHC-independent inhibitory mechanism of cytotoxicity.
title_short CD66a interactions between human melanoma and NK cells: a novel class I MHC-independent inhibitory mechanism of cytotoxicity.
title_sort cd66a interactions between human melanoma and nk cells a novel class i mhc independent inhibitory mechanism of cytotoxicity
work_keys_str_mv AT markelg cd66ainteractionsbetweenhumanmelanomaandnkcellsanovelclassimhcindependentinhibitorymechanismofcytotoxicity
AT liebermann cd66ainteractionsbetweenhumanmelanomaandnkcellsanovelclassimhcindependentinhibitorymechanismofcytotoxicity
AT katzg cd66ainteractionsbetweenhumanmelanomaandnkcellsanovelclassimhcindependentinhibitorymechanismofcytotoxicity
AT arnont cd66ainteractionsbetweenhumanmelanomaandnkcellsanovelclassimhcindependentinhibitorymechanismofcytotoxicity
AT lotemm cd66ainteractionsbetweenhumanmelanomaandnkcellsanovelclassimhcindependentinhibitorymechanismofcytotoxicity
AT drizeo cd66ainteractionsbetweenhumanmelanomaandnkcellsanovelclassimhcindependentinhibitorymechanismofcytotoxicity
AT blumbergr cd66ainteractionsbetweenhumanmelanomaandnkcellsanovelclassimhcindependentinhibitorymechanismofcytotoxicity
AT barhaime cd66ainteractionsbetweenhumanmelanomaandnkcellsanovelclassimhcindependentinhibitorymechanismofcytotoxicity
AT maderr cd66ainteractionsbetweenhumanmelanomaandnkcellsanovelclassimhcindependentinhibitorymechanismofcytotoxicity
AT eisenbachl cd66ainteractionsbetweenhumanmelanomaandnkcellsanovelclassimhcindependentinhibitorymechanismofcytotoxicity
AT mandelboimo cd66ainteractionsbetweenhumanmelanomaandnkcellsanovelclassimhcindependentinhibitorymechanismofcytotoxicity